NF-κB regulates BCL3 transcription in T lymphocytes through an intronic enhancer

Baosheng Ge, Olga Li, Phillip Wilder, A Angie Rizzino, Timothy W. McKeithan

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Exposure to soluble protein Ags in vivo leads to abortive proliferation of responding T cells. In the absence of a danger signal, artificially provided by adjuvants, most responding cells die, and the remainder typically become anergic. The adjuvant-derived signals provided to T cells are poorly understood, but recent work has identified BCL3 as the gene, of those tested, with the greatest differential transcriptional response to adjuvant administration in vivo. As an initial step in analyzing transcriptional responses of BCL3 in T cells, we have identified candidate regulatory regions within the locus through their evolutionary conservation and by analysis of DNase hypersensitivity. An evolutionarily conserved DNase hypersensitive site (HS3) within intron 2 was found to act as a transcriptional enhancer in response to stimuli that mimic TCR activation, namely, PHA and PMA. In luciferase reporter gene constructs transiently transfected into the Jurkat T cell line, the HS3 enhancer can cooperate not only with the BCL3 promoter, but also with an exogenous promoter from herpes simplex thymidine kinase. Deletional analysis revealed that a minimal sequence of ∼81 bp is required for full enhancer activity. At the 5′ end of this minimal sequence is a κB site, as confirmed by EMSAs. Mutation of this site in the context of the full-length HS3 abolished enhancer activity. Cotransfection with NF-κB p65 expression constructs dramatically increased luciferase activity, even without stimulation. Conversely, cotransfection with the NF-κB inhibitor IκBα reduced activation. Together, these results demonstrate a critical role for NF-κB in BCL3 transcriptional up-regulation by TCR-mimetic signals.

Original languageEnglish (US)
Pages (from-to)4210-4218
Number of pages9
JournalJournal of Immunology
Volume171
Issue number8
StatePublished - Oct 15 2003

Fingerprint

T-Lymphocytes
Deoxyribonucleases
Luciferases
Herpes Simplex
Jurkat Cells
Thymidine Kinase
Nucleic Acid Regulatory Sequences
Reporter Genes
Introns
Hypersensitivity
Up-Regulation
Cell Line
Mutation
Genes
Proteins

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

NF-κB regulates BCL3 transcription in T lymphocytes through an intronic enhancer. / Ge, Baosheng; Li, Olga; Wilder, Phillip; Rizzino, A Angie; McKeithan, Timothy W.

In: Journal of Immunology, Vol. 171, No. 8, 15.10.2003, p. 4210-4218.

Research output: Contribution to journalArticle

Ge, B, Li, O, Wilder, P, Rizzino, AA & McKeithan, TW 2003, 'NF-κB regulates BCL3 transcription in T lymphocytes through an intronic enhancer', Journal of Immunology, vol. 171, no. 8, pp. 4210-4218.
Ge, Baosheng ; Li, Olga ; Wilder, Phillip ; Rizzino, A Angie ; McKeithan, Timothy W. / NF-κB regulates BCL3 transcription in T lymphocytes through an intronic enhancer. In: Journal of Immunology. 2003 ; Vol. 171, No. 8. pp. 4210-4218.
@article{63d5e735e6684862ae333a7a0bdbfb60,
title = "NF-κB regulates BCL3 transcription in T lymphocytes through an intronic enhancer",
abstract = "Exposure to soluble protein Ags in vivo leads to abortive proliferation of responding T cells. In the absence of a danger signal, artificially provided by adjuvants, most responding cells die, and the remainder typically become anergic. The adjuvant-derived signals provided to T cells are poorly understood, but recent work has identified BCL3 as the gene, of those tested, with the greatest differential transcriptional response to adjuvant administration in vivo. As an initial step in analyzing transcriptional responses of BCL3 in T cells, we have identified candidate regulatory regions within the locus through their evolutionary conservation and by analysis of DNase hypersensitivity. An evolutionarily conserved DNase hypersensitive site (HS3) within intron 2 was found to act as a transcriptional enhancer in response to stimuli that mimic TCR activation, namely, PHA and PMA. In luciferase reporter gene constructs transiently transfected into the Jurkat T cell line, the HS3 enhancer can cooperate not only with the BCL3 promoter, but also with an exogenous promoter from herpes simplex thymidine kinase. Deletional analysis revealed that a minimal sequence of ∼81 bp is required for full enhancer activity. At the 5′ end of this minimal sequence is a κB site, as confirmed by EMSAs. Mutation of this site in the context of the full-length HS3 abolished enhancer activity. Cotransfection with NF-κB p65 expression constructs dramatically increased luciferase activity, even without stimulation. Conversely, cotransfection with the NF-κB inhibitor IκBα reduced activation. Together, these results demonstrate a critical role for NF-κB in BCL3 transcriptional up-regulation by TCR-mimetic signals.",
author = "Baosheng Ge and Olga Li and Phillip Wilder and Rizzino, {A Angie} and McKeithan, {Timothy W.}",
year = "2003",
month = "10",
day = "15",
language = "English (US)",
volume = "171",
pages = "4210--4218",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

TY - JOUR

T1 - NF-κB regulates BCL3 transcription in T lymphocytes through an intronic enhancer

AU - Ge, Baosheng

AU - Li, Olga

AU - Wilder, Phillip

AU - Rizzino, A Angie

AU - McKeithan, Timothy W.

PY - 2003/10/15

Y1 - 2003/10/15

N2 - Exposure to soluble protein Ags in vivo leads to abortive proliferation of responding T cells. In the absence of a danger signal, artificially provided by adjuvants, most responding cells die, and the remainder typically become anergic. The adjuvant-derived signals provided to T cells are poorly understood, but recent work has identified BCL3 as the gene, of those tested, with the greatest differential transcriptional response to adjuvant administration in vivo. As an initial step in analyzing transcriptional responses of BCL3 in T cells, we have identified candidate regulatory regions within the locus through their evolutionary conservation and by analysis of DNase hypersensitivity. An evolutionarily conserved DNase hypersensitive site (HS3) within intron 2 was found to act as a transcriptional enhancer in response to stimuli that mimic TCR activation, namely, PHA and PMA. In luciferase reporter gene constructs transiently transfected into the Jurkat T cell line, the HS3 enhancer can cooperate not only with the BCL3 promoter, but also with an exogenous promoter from herpes simplex thymidine kinase. Deletional analysis revealed that a minimal sequence of ∼81 bp is required for full enhancer activity. At the 5′ end of this minimal sequence is a κB site, as confirmed by EMSAs. Mutation of this site in the context of the full-length HS3 abolished enhancer activity. Cotransfection with NF-κB p65 expression constructs dramatically increased luciferase activity, even without stimulation. Conversely, cotransfection with the NF-κB inhibitor IκBα reduced activation. Together, these results demonstrate a critical role for NF-κB in BCL3 transcriptional up-regulation by TCR-mimetic signals.

AB - Exposure to soluble protein Ags in vivo leads to abortive proliferation of responding T cells. In the absence of a danger signal, artificially provided by adjuvants, most responding cells die, and the remainder typically become anergic. The adjuvant-derived signals provided to T cells are poorly understood, but recent work has identified BCL3 as the gene, of those tested, with the greatest differential transcriptional response to adjuvant administration in vivo. As an initial step in analyzing transcriptional responses of BCL3 in T cells, we have identified candidate regulatory regions within the locus through their evolutionary conservation and by analysis of DNase hypersensitivity. An evolutionarily conserved DNase hypersensitive site (HS3) within intron 2 was found to act as a transcriptional enhancer in response to stimuli that mimic TCR activation, namely, PHA and PMA. In luciferase reporter gene constructs transiently transfected into the Jurkat T cell line, the HS3 enhancer can cooperate not only with the BCL3 promoter, but also with an exogenous promoter from herpes simplex thymidine kinase. Deletional analysis revealed that a minimal sequence of ∼81 bp is required for full enhancer activity. At the 5′ end of this minimal sequence is a κB site, as confirmed by EMSAs. Mutation of this site in the context of the full-length HS3 abolished enhancer activity. Cotransfection with NF-κB p65 expression constructs dramatically increased luciferase activity, even without stimulation. Conversely, cotransfection with the NF-κB inhibitor IκBα reduced activation. Together, these results demonstrate a critical role for NF-κB in BCL3 transcriptional up-regulation by TCR-mimetic signals.

UR - http://www.scopus.com/inward/record.url?scp=0141923703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141923703&partnerID=8YFLogxK

M3 - Article

C2 - 14530344

AN - SCOPUS:0141923703

VL - 171

SP - 4210

EP - 4218

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -